ATH 25.0% 0.3¢ alterity therapeutics limited

looking good

  1. 11,522 Posts.
    Funding good until well past Phase IIa results, proven results on using substituted 8-quinolinols for treatment of AD, exceptional metal chelation agents, PBT2 improvement on PBT1, then onto the possibility of treating Parkinsons and others.

    Looking to top up, good luck.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.